Publications by authors named "Colin D Marchant"

Claim this Profile
A
A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging.
Melissa S Stockwell, Colin D Marchant, A Patrica Wodi, Elizabeth D Barnett, Karen R Broder

Vaccine· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts' children.
Anita M Loughlin, Katherine Hsu, Amy L Silverio, Colin D Marchant, Stephen I Pelton

Pediatr Infect Dis J· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive assessment of serious adverse events following immunization by health care providers.
S Elizabeth Williams, Kathryn M Edwards, Roger P Baxter, Philip S LaRussa, Neal A Halsey, Colin D Marchant

J Pediatr· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination.
Barbara A Pahud, S Elizabeth Williams, Cornelia L Dekker, Neal Halsey, Philip Larussa, Colin D Marchant

Pediatr Infect Dis J· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologically plausible and evidence-based risk intervals in immunization safety research.
Ali Rowhani-Rahbar, Nicola P Klein, Cornelia L Dekker, Kathryn M Edwards, Colin D Marchant

Vaccine· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
Anita M Loughlin, Colin D Marchant, William Adams, Elizabeth Barnett, Roger Baxter

Vaccine· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and genetic diversity of nontypeable haemophilus influenzae in the respiratory tract of infants and primary caregivers.
Sandra K Schumacher, Colin D Marchant, Anita M Loughlin, Valérie Bouchet, Abbie Stevenson

Pediatr Infect Dis J· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination.
S Elizabeth Williams, Barbara A Pahud, Claudia Vellozzi, Peter D Donofrio, Cornelia L Dekker, Colin D Marchant

Vaccine· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.
S Elizabeth Williams, Nicola P Klein, Neal Halsey, Cornelia L Dekker, Roger P Baxter, Colin D Marchant

Vaccine· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants.
Kristina A Bryant, Gary S Marshall, Colin D Marchant, Noris Pavia-Ruiz, Terry Nolan

Pediatrics· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
Gary S Marshall, Colin D Marchant, Mark Blatter, Leonard R Friedland, Emmanuel Aris

Hum Vaccin· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response and one-year antibody persistence after a fourth dose of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY) at 12 to 15 months of age.
Gary S Marshall, Colin D Marchant, Mark Blatter, Emmanuel Aris, Dominique Boutriau

Pediatr Infect Dis J· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
Colin D Marchant, Jacqueline M Miller, Gary S Marshall, Mark Blatter, Emmanuel Aris

Pediatr Infect Dis J· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly with a pneumococcal conjugate vaccine in healthy children 15 months of age.
Andrew F Trofa, Michael Levin, Colin D Marchant, James Hedrick, Mark M Blatter

Pediatr Infect Dis J· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal hepatitis A vaccination in the United States: a call for action.
Jay M Lieberman, Bonnie M Word, R Jake Jacobs, Ron Dagan, Colin D Marchant

Pediatr Infect Dis J· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad).
Barbara J Kuter, Michelle L Hoffman Brown, Jonathan Hartzel, Wendy R Williams, A EvesiKaren, Colin D Marchant

Hum Vaccin· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.
Stan L Block, Terry Nolan, Carlos Sattler, Eliav Barr, Katherine E D Giacoletti, Colin D Marchant

Pediatrics· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Jay M Lieberman, Wendy R Williams, Jacqueline M Miller, Steven Black, Henry Shinefield, Colin D Marchant

Pediatr Infect Dis J· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Centers for Disease Control and Prevention recommendations for outcomes of acute otitis media.
Howard Bauchner, Colin D Marchant, Alice Bisbee, Timothy Heeren, Bingxia Wang

Pediatrics· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoroquinolone use in children.
Vishakha Sabharwal, Colin D Marchant

Pediatr Infect Dis J· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gatifloxacin therapy for children: an antibiotic still in the "back room".
Colin D Marchant

Clin Infect Dis· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertussis: increasing incidence and the need for booster vaccination in adolescents. Introduction.
Colin D Marchant

Pediatr Infect Dis J· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 100-day cough: the time for prevention has arrived.
Colin D Marchant

Clin Infect Dis· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates.
Stephen I Pelton, Anita M Loughlin, Colin D Marchant

Pediatr Infect Dis J· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute otitis media, antibiotics, children and clinical trial design.
Colin D Marchant

Pediatr Infect Dis J· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis